[Results obtained with the clinical use of adriamycin].
D000328:Adult; D000368:Aged; D000606:Amino Sugars / Q000627:therapeutic use; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D003630:Daunorubicin / Q000627:therapeutic use*; D005260:Female; D006027:Glycosides / Q000627:therapeutic use*; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009279:Naphthacenes / Q000627:therapeutic use; D009369:Neoplasms / Q000188:drug therapy*; D010954:Plasmacytoma / Q000188:drug therapy; D012075:Remission, Spontaneous
D000606:Amino Sugars; D000903:Antibiotics, Antineoplastic; D006027:Glycosides; D009279:Naphthacenes; D003630:Daunorubicin
Risultati ottenuti nell'impiego clinico dell'adriamicina.